Key Values Provided by a Biopharmaceutical Logistics - Market
The Biopharmaceutical Logistics - is growing at a 24% during the forecasted period of 2019 to 2031.Biopharmaceutical Logistics - Market Size in (USD Billion) CAGR Growth Rate 24%
| Study Period | 2019-2031 |
| Market Size (2023): | 3Billion |
| Market Size (2031): | 8Billion |
| CAGR (2023 - 2031): | 24% |
| Fastest Growing Region | Europe |
| Dominating Region | North America |
www.htfmarketinsights.com
Logistics is a key portion of the biopharmaceutical supply chain. network. In an association, coordinations the executives with the acquirement, arranging, and usage of cycle exercises in the forward and pivot the transportation of merchandise starting with one spot on then onto the next. Biopharmaceutical Logistics is the coordination of biopharmaceutical, careful and clinical supplies, and different items expected to help wellbeing subject matter experts, medical caretakers, and dental consideration suppliers. The rising number of biosimilar supports the world over, the creating pattern of rethinking coordinations, and the improvement of a drug dispersion network attributable to its business numbers are a portion of the elements that are inducing the development of the biopharmaceutical coordinations market.
A market research report study provides invaluable data-driven insights that allow businesses to make informed decisions based on accurate market trends, customer behaviors, and competitor analysis. These reports help organizations better understand the evolving needs of their target audience, enabling more customer-focused strategies.
Additionally, they provide a competitive advantage by revealing competitors' strengths and weaknesses, helping companies refine their positioning and stay ahead. Market research reports also play a crucial role in risk reduction by identifying potential challenges, allowing businesses to anticipate and mitigate risks before entering new markets or launching products.
Moreover, these reports uncover growth opportunities and emerging trends, allowing companies to innovate or expand into underserved markets. They are essential for strategic planning, aligning business goals with market realities to ensure long-term success. Investors also rely on market research reports to evaluate industry potential, making these reports key tools for making low-risk investment decisions. A market research report provides essential insights for growth, competitive positioning, and sound business strategy.
Market Dynamics
Influencing Trend:- Last-mile delivery
Market Growth Drivers:
- The Increasing Hype Around Targeted Therapies
- Biologics
Challenges
- Temperature Control
Opportunities
- Expansion In The Demand For Cellular Therapies
- Vaccines
Asia-Pacific is a fast-growing region with high demand for both high-tech and affordable products, driven by urbanization and rising middle-class incomes. Latin America prioritizes affordability amidst economic fluctuations, with Brazil and Mexico leading in market growth. In the Middle East and Africa, market trends are influenced by cultural preferences, with luxury goods prominent in the Gulf States and gradual growth in sub-Saharan Africa. Global trends like sustainability and digital transformation are impacting all regions.
The North America Dominant Region currently dominates the market share, fueled by increasing consumption, population growth, and sustained economic progress, which collectively enhance market demand. Conversely, the Europe is the fastest-growing Region is rapidly becoming the fastest-growing region, driven by significant infrastructure investments, industrial expansion, and rising consumer demand.
Regions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Europe
![Europe dominates Biopharmaceutical Logistics - Market [2019 to 2023]](https://www.htfmarketinsights.com/assets_n/img/region/continent/europe_wn.png)
Dominating Region
North America
![North America dominates Biopharmaceutical Logistics - Market [2019 to 2023]](https://www.htfmarketinsights.com/assets_n/img/region/continent/north_america_wn.png)
Competitive Insights
The key players in the Biopharmaceutical Logistics - are intensifying their focus on research and development (R&D) activities to innovate and stay competitive. Major companies, such as Bio-Pharmaceutical Logistics (Belgium), Amerisource Bergen Corporation (United States), C.H. Robinson Worldwide, Inc. (United States), Ceva Logistics LLC(Netherlands), Deutsche Post DHL Group (Germany), Fedex Corporation (United States), Kuehne + Nagel International AG (Switzerland), Panalpina Group (Switzerland), United Parcel Service, Inc. (United States), XPO Logistics, Inc.( United States) are heavily investing in R&D to develop new products and improve existing ones. This strategic emphasis on innovation drives significant advancements in product formulation and the introduction of sustainable and eco-friendly products.Moreover, these established industry leaders are actively pursuing acquisitions of smaller companies to expand their regional presence and enhance their market share. These acquisitions not only help in diversifying their product portfolios but also provide access to new technologies and markets. This consolidation trend is a critical factor in the growth of the consumer goods industry, as it enables larger companies to streamline operations, reduce costs, and increase their competitive edge.
In addition to R&D and acquisitions, there is a notable shift towards green investments among key players in the consumer goods industry. Companies are increasingly committing resources to sustainable practices and developing environmentally friendly products. This green investment responds to growing consumer demand for sustainable solutions and stringent environmental regulations. By prioritizing sustainability, these companies are not only contributing to environmental protection but also positioning themselves as leaders in the green movement, thereby fueling market growth.
The companies highlighted in this profile were selected based on insights from primary experts and an evaluation of their market penetration, product offerings, and geographical reach:
- Bio-Pharmaceutical Logistics (Belgium)
- Amerisource Bergen Corporation (United States)
- C.H. Robinson Worldwide
- Inc. (United States)
- Ceva Logistics LLC(Netherlands)
- Deutsche Post DHL Group (Germany)
- Fedex Corporation (United States)
- Kuehne + Nagel International AG (Switzerland)
- Panalpina Group (Switzerland)
- United Parcel Service
- Inc. (United States)
- XPO Logistics
- Inc.( United States)
Biopharmaceutical Logistics - Market Segmentation by Players
www.htfmarketinsights.com
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Key Highlights
Segmentation by Type
- Cold storage
- Temperature control
- Distribution
- Packaging
Biopharmaceutical Logistics - Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
-
- Pharma
- Biotech
- Research
- Healthcare
- Manufacturing
Biopharmaceutical Logistics - Market Segmentation by Application
www.htfmarketinsights.com
- Global Import Export in terms of K Tons, K Units, and Metric Tons will be provided if Applicable based on industry best practice
Regional Analysis
The Top-Down and Bottom-Up Approaches
The top-down approach begins with a broad theory or hypothesis and breaks it down into specific components for testing. This structured, deductive process involves developing a theory, creating hypotheses, collecting and analyzing data, and drawing conclusions. It is particularly useful when there is substantial theoretical knowledge, but it can be rigid and may overlook new phenomena.
Conversely, the bottom-up approach starts with specific data or observations, from which broader generalizations and theories are developed. This inductive process involves collecting detailed data, analyzing it for patterns, developing hypotheses, formulating theories, and validating them with additional data. While this approach is flexible and encourages the discovery of new phenomena, it can be time-consuming and less structured.
Swot and Pestal Analysis
SWOT AnalysisSWOT Analysis evaluates a company’s internal Strengths and Weaknesses, as well as external Opportunities and Threats. This analysis helps businesses identify their competitive advantages, address internal challenges, and seize external opportunities while mitigating potential risks. It is performed to gain a comprehensive understanding of the organization's position in the market, align strategies with its strengths, and effectively navigate competitive landscapes.
PESTEL Analysis
Political, Economic, Social, Technological, Environmental, and Legal factors impacting the business environment. This analysis helps organizations anticipate external changes, adapt strategies to macroeconomic trends, and ensure compliance with regulatory requirements. It is crucial for understanding the external forces that could influence business operations and for planning long-term strategies that align with evolving market conditions.
Report Infographics:
| Report Features | Details |
| Base Year | 2023 |
| Based Year Market Size 2023 | 3Billion |
| Historical Period | 2019 |
| CAGR (2023 to 2031) | 24% |
| Forecast Period | 2031 |
| Forecasted Period Market Size (2031) | 8Billion |
| Scope of the Report |
Cold storage, Temperature control, Distribution, Packaging Pharma, Biotech, Research, Healthcare, Manufacturing |
| Regions Covered | North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
| Companies Covered | Bio-Pharmaceutical Logistics (Belgium), Amerisource Bergen Corporation (United States), C.H. Robinson Worldwide, Inc. (United States), Ceva Logistics LLC(Netherlands), Deutsche Post DHL Group (Germany), Fedex Corporation (United States), Kuehne + Nagel International AG (Switzerland), Panalpina Group (Switzerland), United Parcel Service, Inc. (United States), XPO Logistics, Inc.( United States) |
| Customization Scope | 15% Free Customization (For EG) |
| Delivery Format | PDF and Excel through Email |
Biopharmaceutical Logistics - - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Biopharmaceutical Logistics - Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Biopharmaceutical Logistics - Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Biopharmaceutical Logistics - Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 The increasing hype around targeted therapies
- 3.1.2 biologics
-
3.2 Available Opportunities
- 3.2.1 Expansion in the demand for cellular therapie
-
3.3 Influencing Trends
- 3.3.1 Last-mile delivery
- 3.3.2 AI optimization
-
3.4 Challenges
- 3.4.1 Temperature control
- 3.4.2 packaging regulations
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Biopharmaceutical Logistics - Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Biopharmaceutical Logistics - Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Biopharmaceutical Logistics - : Competition Benchmarking & Performance Evaluation
- 5.1 Global Biopharmaceutical Logistics - Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Biopharmaceutical Logistics - Revenue 2023
- 5.3 Global Biopharmaceutical Logistics - Sales Volume by Manufacturers (2023)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Ansoff Matrix
- 5.6 FPNV Positioning Matrix
Chapter 6: Global Biopharmaceutical Logistics - Market: Company Profiles
- 6.1 Bio-Pharmaceutical Logistics (Belgium)
- 6.1.1 Bio-Pharmaceutical Logistics (Belgium) Company Overview
- 6.1.2 Bio-Pharmaceutical Logistics (Belgium) Product/Service Portfolio & Specifications
- 6.1.3 Bio-Pharmaceutical Logistics (Belgium) Key Financial Metrics
- 6.1.4 Bio-Pharmaceutical Logistics (Belgium) SWOT Analysis
- 6.1.5 Bio-Pharmaceutical Logistics (Belgium) Development Activities
- 6.2 Amerisource Bergen Corporation (United States)
- 6.3 C.H. Robinson Worldwide
- 6.4 Inc. (United States)
- 6.5 Ceva Logistics LLC(Netherlands)
- 6.6 Deutsche Post DHL Group (Germany)
- 6.7 Fedex Corporation (United States)
- 6.8 Kuehne + Nagel International AG (Switzerland)
- 6.9 Panalpina Group (Switzerland)
- 6.10 United Parcel Service
- 6.11 Inc. (United States)
- 6.12 XPO Logistics
- 6.13 Inc.( United States)
- 6.14
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Biopharmaceutical Logistics - by Type & Application (2019-2031)
-
7.1 Global Biopharmaceutical Logistics - Market Revenue Analysis (USD Million) by Type (2019-2023)
- 7.1.1 Cold Storage
- 7.1.2 Temperature Control
- 7.1.3 Distribution
- 7.1.4 Packaging
- 7.1.5 Transportation
-
7.2 Global Biopharmaceutical Logistics - Market Revenue Analysis (USD Million) by Application (2019-2023)
- 7.2.1 Pharma
- 7.2.2 Biotech
- 7.2.3 Research
- 7.2.4 Healthcare
- 7.2.5 Manufacturing
- 7.3 Global Biopharmaceutical Logistics - Market Revenue Analysis (USD Million) by Type (2023-2031)
- 7.4 Global Biopharmaceutical Logistics - Market Revenue Analysis (USD Million) by Application (2023-2031)
Chapter 8 : North America Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 8.1 North America Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 8.2.1 Cold Storage
- 8.2.2 Temperature Control
- 8.2.3 Distribution
- 8.2.4 Packaging
- 8.2.5 Transportation
-
8.3 North America Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 8.3.1 Pharma
- 8.3.2 Biotech
- 8.3.3 Research
- 8.3.4 Healthcare
- 8.3.5 Manufacturing
- 8.4 North America Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 8.5 North America Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 8.6 North America Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 9.1 LATAM Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 9.2.1 Cold Storage
- 9.2.2 Temperature Control
- 9.2.3 Distribution
- 9.2.4 Packaging
- 9.2.5 Transportation
-
9.3 LATAM Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 9.3.1 Pharma
- 9.3.2 Biotech
- 9.3.3 Research
- 9.3.4 Healthcare
- 9.3.5 Manufacturing
- 9.4 LATAM Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 9.5 LATAM Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 9.6 LATAM Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 10 : West Europe Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 10.1 West Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 10.2.1 Cold Storage
- 10.2.2 Temperature Control
- 10.2.3 Distribution
- 10.2.4 Packaging
- 10.2.5 Transportation
-
10.3 West Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 10.3.1 Pharma
- 10.3.2 Biotech
- 10.3.3 Research
- 10.3.4 Healthcare
- 10.3.5 Manufacturing
- 10.4 West Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 10.5 West Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 10.6 West Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 11 : Central & Eastern Europe Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 11.2.1 Cold Storage
- 11.2.2 Temperature Control
- 11.2.3 Distribution
- 11.2.4 Packaging
- 11.2.5 Transportation
-
11.3 Central & Eastern Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 11.3.1 Pharma
- 11.3.2 Biotech
- 11.3.3 Research
- 11.3.4 Healthcare
- 11.3.5 Manufacturing
- 11.4 Central & Eastern Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 11.5 Central & Eastern Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 11.6 Central & Eastern Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 12 : Northern Europe Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 12.2.1 Cold Storage
- 12.2.2 Temperature Control
- 12.2.3 Distribution
- 12.2.4 Packaging
- 12.2.5 Transportation
-
12.3 Northern Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 12.3.1 Pharma
- 12.3.2 Biotech
- 12.3.3 Research
- 12.3.4 Healthcare
- 12.3.5 Manufacturing
- 12.4 Northern Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 12.5 Northern Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 12.6 Northern Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 13 : Southern Europe Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 13.2.1 Cold Storage
- 13.2.2 Temperature Control
- 13.2.3 Distribution
- 13.2.4 Packaging
- 13.2.5 Transportation
-
13.3 Southern Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 13.3.1 Pharma
- 13.3.2 Biotech
- 13.3.3 Research
- 13.3.4 Healthcare
- 13.3.5 Manufacturing
- 13.4 Southern Europe Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 13.5 Southern Europe Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 13.6 Southern Europe Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 14 : East Asia Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 14.1 East Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 14.2.1 Cold Storage
- 14.2.2 Temperature Control
- 14.2.3 Distribution
- 14.2.4 Packaging
- 14.2.5 Transportation
-
14.3 East Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 14.3.1 Pharma
- 14.3.2 Biotech
- 14.3.3 Research
- 14.3.4 Healthcare
- 14.3.5 Manufacturing
- 14.4 East Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 14.5 East Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 14.6 East Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 15 : Southeast Asia Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 15.2.1 Cold Storage
- 15.2.2 Temperature Control
- 15.2.3 Distribution
- 15.2.4 Packaging
- 15.2.5 Transportation
-
15.3 Southeast Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 15.3.1 Pharma
- 15.3.2 Biotech
- 15.3.3 Research
- 15.3.4 Healthcare
- 15.3.5 Manufacturing
- 15.4 Southeast Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 15.5 Southeast Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 15.6 Southeast Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 16 : South Asia Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 16.1 South Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 16.2.1 Cold Storage
- 16.2.2 Temperature Control
- 16.2.3 Distribution
- 16.2.4 Packaging
- 16.2.5 Transportation
-
16.3 South Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 16.3.1 Pharma
- 16.3.2 Biotech
- 16.3.3 Research
- 16.3.4 Healthcare
- 16.3.5 Manufacturing
- 16.4 South Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 16.5 South Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 16.6 South Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 17 : Central Asia Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 17.1 Central Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 17.2.1 Cold Storage
- 17.2.2 Temperature Control
- 17.2.3 Distribution
- 17.2.4 Packaging
- 17.2.5 Transportation
-
17.3 Central Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 17.3.1 Pharma
- 17.3.2 Biotech
- 17.3.3 Research
- 17.3.4 Healthcare
- 17.3.5 Manufacturing
- 17.4 Central Asia Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 17.5 Central Asia Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 17.6 Central Asia Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 18 : Oceania Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 18.1 Oceania Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 18.2.1 Cold Storage
- 18.2.2 Temperature Control
- 18.2.3 Distribution
- 18.2.4 Packaging
- 18.2.5 Transportation
-
18.3 Oceania Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 18.3.1 Pharma
- 18.3.2 Biotech
- 18.3.3 Research
- 18.3.4 Healthcare
- 18.3.5 Manufacturing
- 18.4 Oceania Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 18.5 Oceania Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 18.6 Oceania Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 19 : MEA Biopharmaceutical Logistics - Market Breakdown by Country, Type & Application
- 19.1 MEA Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
- 19.2.1 Cold Storage
- 19.2.2 Temperature Control
- 19.2.3 Distribution
- 19.2.4 Packaging
- 19.2.5 Transportation
-
19.3 MEA Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
- 19.3.1 Pharma
- 19.3.2 Biotech
- 19.3.3 Research
- 19.3.4 Healthcare
- 19.3.5 Manufacturing
- 19.4 MEA Biopharmaceutical Logistics - Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
- 19.5 MEA Biopharmaceutical Logistics - Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
- 19.6 MEA Biopharmaceutical Logistics - Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Global Biopharmaceutical Logistics - market size surpassed 3Billion in 2023 and will expand at a CAGR of 24% between 2023 and 2031.
The Biopharmaceutical Logistics - Market is growing at a CAGR of 24% over the forecasted period 2023 - 2031.
Some of the prominent trends that are influencing and driving the growth of Global Biopharmaceutical Logistics - Market are Last-mile Delivery, AI Optimization
- The Increasing Hype Around Targeted Therapies
- Biologics
- And Personalized Medicines Demand Better Temperature Control Measures In The Biopharmaceutical Supply Chain
Business transformation in Biopharmaceutical Logistics - Market has taken hold due to the confluence of several important triggers, some of them are Temperature Control, Packaging Regulations.
The market opportunity is clear from the flow of investment into Global Biopharmaceutical Logistics - Market, some of them are Expansion In The Demand For Cellular Therapies, Vaccines, And Blood Products In The Bio-pharmaceutical Industry Driving The Growth Of The Bio-pharmaceutical Logistics Market Across The Globe..
Biopharmaceutical Logistics - Market identifies market share by players along with the concentration rate using CR4, CR8 Index to determine leading and emerging competitive players such as Bio-Pharmaceutical Logistics (Belgium), Amerisource Bergen Corporation (United States), C.H. Robinson Worldwide, Inc. (United States), Ceva Logistics LLC(Netherlands), Deutsche Post DHL Group (Germany), Fedex Corporation (United States), Kuehne + Nagel International AG (Switzerland), Panalpina Group (Switzerland), United Parcel Service, Inc. (United States), XPO Logistics, Inc.( United States), .
Research paper of Global Biopharmaceutical Logistics - Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Pharma, Biotech, Research, Healthcare, Manufacturing.
The Global Biopharmaceutical Logistics - Market Study is segmented by Cold storage, Temperature control, Distribution, Packaging, Transportation.
The Global Biopharmaceutical Logistics - Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
The Biopharmaceutical Logistics - Market is studied from 2019 - 2031.
Logistics is a key portion of the biopharmaceutical supply chain. network. In an association, coordinations the executives with the acquirement, arranging, and usage of cycle exercises in the forward and pivot the transportation of merchandise starting with one spot on then onto the next. Biopharmaceutical Logistics is the coordination of biopharmaceutical, careful and clinical supplies, and different items expected to help wellbeing subject matter experts, medical caretakers, and dental consideration suppliers. The rising number of biosimilar supports the world over, the creating pattern of rethinking coordinations, and the improvement of a drug dispersion network attributable to its business numbers are a portion of the elements that are inducing the development of the biopharmaceutical coordinations market.
